Literature DB >> 25007046

KIR3DL2/CpG ODN interaction mediates Sézary syndrome malignant T cell apoptosis.

Bouchra Ghazi1, Nicolas Thonnart2, Martine Bagot3, Armand Bensussan3, Anne Marie-Cardine4.   

Abstract

We previously identified the NK cell receptor KIR3DL2 as a valuable diagnostic and prognostic marker for the detection of the tumoral T cell burden of Sézary syndrome (SS) patients. However, the function of this receptor on the malignant T lymphocyte population remained unexplored. We here demonstrate that engagement of KIR3DL2 by its recently identified ligand CpG oligodeoxynucleotide (ODN) induces the internalization of the receptor and leads to a caspase-dependent apoptosis of malignant T cells. This process of cellular death is correlated to a dephosphorylation of the transcription factor STAT3 (signal transducer and activator of transcription 3), which is found constitutively phosphorylated and activated in Sézary cells. Our results indicate that KIR3DL2 can directly promote SS malignant cell death through the use of CpG ODN.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25007046     DOI: 10.1038/jid.2014.286

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Silencing autocrine death: a ubiquitin ligase that blocks activation-induced cell death in cutaneous T-cell lymphoma.

Authors:  Claus-Detlev Klemke; Maria Feoktistova; Martin Leverkus
Journal:  J Invest Dermatol       Date:  2015-03       Impact factor: 8.551

2.  Profile of differentially expressed Toll-like receptor signaling genes in the natural killer cells of patients with Sézary syndrome.

Authors:  Kelly C G ManfrereC; Marina P Torrealba; Denis R Miyashiro; Nátalli Z Pereira; Fabio S Y Yoshikawa; Luana de M Oliveira; Jade Cury-Martins; Alberto J S Duarte; José A Sanches; Maria N Sato
Journal:  Oncotarget       Date:  2017-09-18

Review 3.  Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas.

Authors:  Christian Schmitt; Anne Marie-Cardine; Armand Bensussan
Journal:  Front Immunol       Date:  2017-08-30       Impact factor: 7.561

Review 4.  An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More.

Authors:  Massimo Vitale; Claudia Cantoni; Mariella Della Chiesa; Guido Ferlazzo; Simona Carlomagno; Daniela Pende; Michela Falco; Annamaria Pessino; Letizia Muccio; Andrea De Maria; Emanuela Marcenaro; Lorenzo Moretta; Simona Sivori
Journal:  Front Immunol       Date:  2019-06-19       Impact factor: 7.561

5.  The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma.

Authors:  Armand Bensussan; Anne Marie-Cardine; Marie-Léa Gauci; Jérôme Giustiniani; Clémence Lepelletier; Christian Garbar; Nicolas Thonnart; Nicolas Dumaz; Arnaud Foussat; Céleste Lebbé
Journal:  Cancer Immunol Immunother       Date:  2022-04-15       Impact factor: 6.630

6.  Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming.

Authors:  Sylvain Carras; Dimitri Chartoire; Sylvain Mareschal; Maël Heiblig; Antoine Marçais; Rémy Robinot; Mirjam Urb; Roxane M Pommier; Edith Julia; Amel Chebel; Aurélie Verney; Charlotte Bertheau; Emilie Bardel; Caroline Fezelot; Lucien Courtois; Camille Lours; Alyssa Bouska; Sunandini Sharma; Christine Lefebvre; Jean-Pierre Rouault; David Sibon; Anthony Ferrari; Javeed Iqbal; Laurence de Leval; Philippe Gaulard; Alexandra Traverse-Glehen; Pierre Sujobert; Mathieu Blery; Gilles Salles; Thierry Walzer; Emmanuel Bachy; Laurent Genestier
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.